Table 1.
Patient characteristics (n = 40)
| Standard dose (n = 10) | Modified dose (n = 18) | Lower dose (n = 12) | |
|---|---|---|---|
| Median age (range) | 74 (70-91) | 73 (70-81) | 82 (71-86) |
| Performance status | |||
| ECOG 1 | 3 | 5 | 0 |
| ECOG 2 | 7 | 13 | 12 |
| Gender | |||
| Male | 8 | 16 | 9 |
| Female | 2 | 2 | 3 |
| Tumor location | |||
| Upper thoracic | 2 | 3 | 3 |
| Middle thoracic | 7 | 8 | 3 |
| Lower thoracic | 1 | 7 | 6 |
| AJCC stage | |||
| I | 0 | 0 | 0 |
| II | 2 | 2 | 1 |
| III | 6 | 14 | 10 |
| IV | 2 | 2 | 1 |
| Response | |||
| CR + PR | 6 | 15 | 7 |
| SD + PD | 4 | 3 | 5 |
AJCC = American Joint Committee on Cancer; CR = complete response; ECOG = Eastern Cooperative Oncology Group; PD = progression disease; PR = partial response; SD = stable disease.